Systrade’s BioNTech BNTX Stock Holding History

Systrade’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$931K	Hold	10,000	–	–	0.58%	11
2026 Q1	$889K	Hold	10,000	–	–	0.6%	10
2025 Q4	$952K	Hold	10,000	–	–	0.58%	12
2025 Q3	$986K	Hold	10,000	–	–	0.73%	9
2025 Q2	$1.06M	Hold	10,000	–	–	1.21%	10
2025 Q1	$911K	Hold	10,000	–	–	1.27%	8
2024 Q4	$1.05M	Hold	10,000	–	–	1.79%	8
2024 Q3	$1.05M	Hold	10,000	–	–	2.21%	5
2024 Q2	$804K	Hold	10,000	–	–	1.38%	3
2024 Q1	$923K	Hold	10,000	–	–	1.12%	3
2023 Q4	$1.06M	Sell	10,000 -40,000	-80%	-$4.03M	0.95%	4
2023 Q3	$5.43M	Hold	50,000	–	–	4.7%	3
2023 Q2	$5.4M	Buy	50,000 +40,000	+400%	+$4.5M	6.54%	4
2023 Q1	$1.25M	Hold	10,000	–	–	0.74%	6
2022 Q4	$1.5M	Buy	+10,000	New	+$1.54M	1.29%	6

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Systrade's BNTX Position: Q2 2026 in Review

Systrade held its BioNTech (BNTX) position steady in Q2 2026 at 10,000 shares worth $931K. The position accounts for 0.58% of the portfolio, ranked #11.

Systrade first reported a position in BNTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.43M in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Systrade held 10,000 shares of BioNTech worth $931K as of Q2 2026.
Systrade left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.58% of Systrade's portfolio in Q2 2026, its #11 holding.
Systrade first reported a position in BioNTech in Q4 2022 and has held it in 15 quarters since.
Systrade's BioNTech position peaked at $5.43M in Q3 2023.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Systrade's 13F filing for Q2 2026, filed 7 Jul 2026.